Brilliant Violet 421# anti-mouse CD274 ( and 3 more items

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has awarded a purchase order (PO) to BioLegend Inc., a scientific reagent provider located in Pasadena, California. The contract, numbered 4800137812, was issued on August 26, 2025, with a completion date of September 3, 2025, and a total contract value of $1,828.50. The procurement is for specialized antibody research reagents critical to immunological research.

The specific line items include four distinct antibody products: three units of Brilliant Violet 421# anti-mouse CD274 and three units of Brilliant Violet 570# anti-mouse CD11c C, each priced at $153.00, four units of Brilliant Violet 650# anti-mouse CD86 Cl at $169.50 each, and one unit of PE anti-mouse CD279 (PD-1) Clone: 29F.1A at $232.50. The purchase order is tax-exempt under Nebraska state tax number 05-8905401 and adheres to the University of Nebraska's Standard Terms of Purchase, with payment terms set at Net 30. The contract appears to support scientific research activities at the university's medical center.